Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis

Medicine and Dentistry

• Fluconazole 100%
• Candidiasis 40%
• Patient 40%
• Pyrrole 20%
• Effusion 20%
• Gene 20%
• Therapeutic Procedure 20%
• Human Immunodeficiency Virus 10%
• Enzyme 10%
• Antifungal Agent 10%
• Combination Therapy 10%
• Surveillance 10%
• Amino Acid Substitution 10%
• Oral Cavity 10%
• Point Mutation 10%
• Lanosterol 14 Alpha-Demethylase 10%
• Development 10%
• Drug 10%
• Chemotherapeutic Agent 10%
• Analysis 10%
• Culture 10%
• Absence 10%
• Pump 10%
• Relapse 10%

Immunology and Microbiology

• Candida Albicans 50%
• Gene 20%
• Sample 20%
• Time 20%
• Human Immunodeficiency Virus 10%
• Minimum Inhibitory Concentration 10%
• Mutation 10%
• Amino Acid Substitution 10%
• Point Mutation 10%
• DNA Fingerprinting 10%
• Development 10%
• Pressure 10%
• Dose 10%